argenx to Host Myositis R&D Webinar on June 23, 2026
May 28, 2026 01:00 ET | Source: argenx SE May 28, 2026Amsterdam,…
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund…
Beko’s Global R&D Network Engineers the Future of Home Living with AI, Agility and Consumer-First Innovation
With 28 R&D centers across 12 countries and over 2,000 R&D employees,…
Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund…
Immunocore announces R&D leadership evolution
Immunocore announces R&D leadership evolution Dr. David Berman will depart the Company…
Genmab to Hold 2025 R&D Update and ASH Data Review Meeting
Media Release Event to be held virtually via live webcast and archived…
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
November 02, 2025 19:00 ET | Source: HUTCHMED (China) Limited — HUTCHMED…
Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University
TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
izmo Ltd. Receives Prestigious DSIR Recognition for In-House R&D Unit
BANGALORE, India, Oct. 16, 2025 /PRNewswire/ -- izmo Ltd., has been formally…
Benchling Reveals the Next Chapter of R&D at Benchtalk 2025
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data…
